A bumetanide nasal spray in development for heart failure was well-tolerated and showed reliable rates of absorption compared ...

Heart failure is responsible for 13 percent of deaths worldwide, and half of patients die within 5 years. New therapies are ...

Valuable data can successfully be collected with the noninvasive wearable, which is worn on the sternum, report investigators ...